Point72 Hong Kong LTD Macrogenics Inc Transaction History

Point72 Hong Kong LTD

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $44,820 - $199,000	19,920 New	19,920 $59,000
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $43,531 - $90,600	-5,361 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $43,052 - $59,207	2,706 Added 101.92%	5,361 $86,000
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $108,945 - $158,395	-5,519 Reduced 67.52%	2,655 $56,000
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $155,785 - $270,894	7,603 Added 1331.52%	8,174 $220,000
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $10,843 - $18,957	571 New	571 $18,000
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $15,727 - $20,129	-637 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $1,679 - $9,405	323 Added 102.87%	637 $18,000
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $1,343 - $3,802	314 New	314 $2,000
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $24,783 - $33,664	-1,708 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $14,654 - $33,766	1,319 Added 339.07%	1,708 $31,000
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $4,570 - $8,332	389 New	389 $5,000
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $1,637 - $1,994	-85 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$19.78 - $24.67 $35,742 - $44,578	-1,807 Reduced 95.51%	85 $2,000
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $34,436 - $59,174	1,823 Added 2642.03%	1,892 $48,000
Q4 2017 Feb 14, 2018	SELL	$16.19 - $20.3 $291 - $365	-18 Reduced 20.69%	69 $1,000
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $1,350 - $1,647	87	87 $2,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.